29/05/2026
On 27th and 28th May 2026, Rachuonyo Clinical Trial Centre (RCTC) successfully hosted its first Quality Oversight Visit conducted by the CRM/CCQM team from MSD for the MK-8527 Phase III study evaluating the once-monthly HIV PrEP pill.
This marked an important milestone for our site as the MK-8527 study is the first clinical trial being conducted at RCTC. The visit provided a valuable opportunity for learning, mentorship, and strengthening our research processes to ensure the highest standards of quality in clinical trial conduct.
We are grateful to the MSD CRM/CCQM team for their guidance, support, and constructive engagement throughout the visit. The experience has greatly enhanced our capacity and confidence as we continue contributing to innovative HIV prevention research.